Modelling the Human Immune System Response to the ChAdOx1 nCoV-19 Vaccine

About seven months after the start of the COVID-19 pandemic, the first vaccine against the disease was approved for emergency use. Since then, twenty-three more vaccines have been approved, while more than three hundred are in development. Despite being one of the fastest vaccines ever created, several questions about it remain open. Computational models can be useful to answer some of these questions. This paper aims to evaluate whether a computer model previously used to reproduce the effects of the yellow fever vaccine in the body is also capable of reproducing the effects of a distinct vaccine: ChAdOx1 nCoV-19. Preliminary results show that the model is a promising tool to achieve this goal since it was able to reproduce the antibody curves observed in individuals vaccinated with ChAdOx1 nCoV-19.